RxDoctor Payments Data

Katherine Schultz, PA

Physician Assistant · Huntersville, NCNPI 1508139403

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $147,835 of the $164,261 with a category attached, or 90.0%. AbbVie accounts for 99.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $105,596 and has fallen 99.8% since, to $252 in 2025. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$164,261in general payments, 2019–2025

Across 306 payments — averaging $536.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$164K
  • Lilly USA, LLC$251
  • Biogen$121
  • Johnson & Johnson$91
  • Pfizer$80
  • Biohaven Pharmaceutical Holding Company Ltd.$78
  • plus $105 from 3 others

What the payments were for

  • Speaking & faculty fees$147,83590%
  • Travel & lodging$10,4506%
  • Food & beverage$5,9634%
  • Education$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$164,261 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$36,916
Medicare patients
20
Services billed
5,899

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant71$108,235
Emgality PenGalcanezumab-Gnlm54$59,485
Nurtec OdtRimegepant Sulfate25$26,334
Aimovig AutoinjectorErenumab-Aooe12$17,398
Emgality SyringeGalcanezumab-Gnlm12$16,398
Ajovy AutoinjectorFremanezumab-Vfrm14$14,342
QuliptaAtogepant14$14,262
Sumatriptan Succinate33$1,103
Ondansetron OdtOndansetron32$850
Sumatriptan11$560
Topiramate55$511
Tizanidine Hcl37$489
Divalproex Sodium ErDivalproex Sodium14$317
Nortriptyline Hcl24$305
Prochlorperazine Maleate13$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$163,535$122,49685 claims
PfizerNurtec Odt$80$26,33425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Huntersville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →